EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biotechnology and the Development of Antimicrobial Peptides

Thomas Fisher, Rachel Turner

American Journal of Biotechnology · 31.10.2025 · 6 (5) · 11-15

DOI: 10.71465/ajbt3488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Biotechnology, online erschienen am 31.10.2025. Verfasst von Thomas Fisher und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing global threat of antimicrobial resistance (AMR) has led to an increasing need for the development of novel antimicrobial agents. Antimicrobial peptides (AMPs), naturally occurring molecules with broad-spectrum activity against bacteria, fungi, and viruses, have emerged as promising candidates in the fight against AMR. Biotechnology plays a critical role in the discovery, optimization, and large-scale production of AMPs. This article explores the biotechnological advances in AMP development, focusing on their mechanisms of action, therapeutic potential, and challenges in clinical application. The article also discusses the future directions of AMP research and their role in the development of new antimicrobial therapies

Zitieren

APA

Fisher, T., & Turner, R. (2025). Biotechnology and the Development of Antimicrobial Peptides. American Journal of Biotechnology, 6(5), 11-15. https://doi.org/10.71465/ajbt3488

Vancouver

Fisher T, Turner R. Biotechnology and the Development of Antimicrobial Peptides. American Journal of Biotechnology. 2025;6(5):11-15. doi:10.71465/ajbt3488

BibTeX
@article{Fisher2025,
  author = {Fisher, Thomas and Turner, Rachel},
  title = {Biotechnology and the Development of Antimicrobial Peptides},
  journal = {American Journal of Biotechnology},
  year = {2025},
  volume = {6},
  number = {5},
  pages = {11--15},
  doi = {10.71465/ajbt3488}
}
Kostenlos starten →